产品标题 产品货号 产品规格 厂家
Human Duodenum, normal from ORIGENE TECHNOLOGIESCS6040915x5umORIGENE TECHNOLOGIES
Human Duodenum, normal from ORIGENE TECHNOLOGIESCS6047335x5umORIGENE TECHNOLOGIES
Human Duodenum, normal from ORIGENE TECHNOLOGIESCS6047345x5umORIGENE TECHNOLOGIES
Human EG-VEGF ELISA Kit from ORIGENE TECHNOLOGIESEA1003968x12 divisible stripORIGENE TECHNOLOGIES
Human EH-domain containing 1 (EHD1) from ORIGENE TECHNOLOGIESTP31115820 ugORIGENE TECHNOLOGIES
Human EH-domain containing 2 (EHD2) from ORIGENE TECHNOLOGIESTP30484820 ugORIGENE TECHNOLOGIES
Human EH-domain containing 3 (EHD3) from ORIGENE TECHNOLOGIESTP31416820 ugORIGENE TECHNOLOGIES
Human elaC homolog 1 (E. coli) (ELAC1) from ORIGENE TECHNOLOGIESTP30138820 ugORIGENE TECHNOLOGIES
Human elaC homolog 2 (E. coli) (ELAC2) from ORIGENE TECHNOLOGIESTP30076420 ugORIGENE TECHNOLOGIES
Human Elafin/PI3 ELISA Kit from ORIGENE TECHNOLOGIESEA1006558x12 divisible stripORIGENE TECHNOLOGIES
Human elastase 2B (ELA2B) from ORIGENE TECHNOLOGIESTP31012620 ugORIGENE TECHNOLOGIES
Human elastin microfibril interfacer 2 (EMILIN2) from ORIGENE TECHNOLOGIESTP31403820 ugORIGENE TECHNOLOGIES
Human ELAV (embryonic lethal, abnormal vision, Drosophila)-like 3 (Hu antigen C) (ELAVL3), transcript variant 1 from ORIGENE TECHNOLOGIESTP30432320 ugORIGENE TECHNOLOGIES
Human ELAV (embryonic lethal, abnormal vision, Drosophila)-like 4 (Hu antigen D) (ELAVL4), transcript variant 1 from ORIGENE TECHNOLOGIESTP31861220 ugORIGENE TECHNOLOGIES
Human ELAV (embryonic lethal, abnormal vision, Drosophila)-like 1 (Hu antigen R) (ELAVL1) from ORIGENE TECHNOLOGIESTP30156220 ugORIGENE TECHNOLOGIES
Human electron-transfer-flavoprotein, alpha polypeptide (ETFA), nuclear gene encoding mitochondrial protein, transcript variant 1, full length from ORIGENE TECHNOLOGIESTP76007350 ugORIGENE TECHNOLOGIES
Human electron-transfer-flavoprotein, beta polypeptide (ETFB), transcript variant 1 from ORIGENE TECHNOLOGIESTP31089420 ugORIGENE TECHNOLOGIES
Human electron-transfer-flavoprotein, beta polypeptide (ETFB), transcript variant 1 from ORIGENE TECHNOLOGIESTP72098010 ugORIGENE TECHNOLOGIES
Human E74-like factor 2 (ets domain transcription factor) (ELF2), transcript variant 2, full length from ORIGENE TECHNOLOGIESTP76028850 ugORIGENE TECHNOLOGIES
Human E74-like factor 1 (ets domain transcription factor) (ELF1), transcript variant 1, full length from ORIGENE TECHNOLOGIESTP76062950 ugORIGENE TECHNOLOGIES
Human E74-like factor 3 (ets domain transcription factor, epithelial-specific ) (ELF3), transcript variant 1 from ORIGENE TECHNOLOGIESTP30063120 ugORIGENE TECHNOLOGIES
Human ELK3, ETS-domain protein (SRF accessory protein 2) (ELK3) from ORIGENE TECHNOLOGIESTP30311420 ugORIGENE TECHNOLOGIES
Human ELK4, ETS-domain protein (SRF accessory protein 1) (ELK4), transcript variant a, full length from ORIGENE TECHNOLOGIESTP76036450 ugORIGENE TECHNOLOGIES
Human ELK4, ETS-domain protein (SRF accessory protein 1) (ELK4), transcript variant b from ORIGENE TECHNOLOGIESTP30957220 ugORIGENE TECHNOLOGIES
Human ELKS/RAB6-interacting/CAST family member 1 (ERC1), transcript variant epsilon from ORIGENE TECHNOLOGIESTP31386420 ugORIGENE TECHNOLOGIES
Human ELL associated factor 2 (EAF2) from ORIGENE TECHNOLOGIESTP30431420 ugORIGENE TECHNOLOGIES
Human ELL associated factor 1 (EAF1) from ORIGENE TECHNOLOGIESTP30716920 ugORIGENE TECHNOLOGIES
Human Ellis van Creveld syndrome (EVC) from ORIGENE TECHNOLOGIESTP32438220 ugORIGENE TECHNOLOGIES
Human Endometriotic tissue; Adenomyosis of myometrium from ORIGENE TECHNOLOGIESCS7016715x5umORIGENE TECHNOLOGIES
Human Endometriotic tissue; Adenomyosis of myometrium from ORIGENE TECHNOLOGIESCS7019265x5umORIGENE TECHNOLOGIES
Human Endometriotic tissue; Adenomyosis of myometrium from ORIGENE TECHNOLOGIESCS7029295x5umORIGENE TECHNOLOGIES
Human Endometriotic tissue; Adenomyosis of myometrium from ORIGENE TECHNOLOGIESCS7029705x5umORIGENE TECHNOLOGIES
Human Endometriotic tissue; Adenomyosis of myometrium from ORIGENE TECHNOLOGIESCS7029715x5umORIGENE TECHNOLOGIES
Human Endometriotic tissue; Adenomyosis of myometrium from ORIGENE TECHNOLOGIESCS8056185x5umORIGENE TECHNOLOGIES
Human Endometriotic tissue; Adenomyosis of myometrium from ORIGENE TECHNOLOGIESCS8100885x5umORIGENE TECHNOLOGIES
Human Endometriotic tissue; Adenomyosis of myometrium from ORIGENE TECHNOLOGIESCS8113485x5umORIGENE TECHNOLOGIES
Human Endometriotic tissue; Adenomyosis of myometrium from ORIGENE TECHNOLOGIESCS5057535x5umORIGENE TECHNOLOGIES
Human Endometriotic tissue; Adenomyosis of myometrium from ORIGENE TECHNOLOGIESCS5057545x5umORIGENE TECHNOLOGIES
Human Endometriotic tissue; Adenomyosis of myometrium from ORIGENE TECHNOLOGIESCS5066665x5umORIGENE TECHNOLOGIES
Human Endometriotic tissue; Adenomyosis of myometrium from ORIGENE TECHNOLOGIESCS5066675x5umORIGENE TECHNOLOGIES
Human Endometriotic tissue; Adenomyosis of myometrium from ORIGENE TECHNOLOGIESCS5066685x5umORIGENE TECHNOLOGIES
Human Endometriotic tissue; Adenomyosis of myometrium from ORIGENE TECHNOLOGIESCS5115265x5umORIGENE TECHNOLOGIES
Human Endometriotic tissue; Adenomyosis of myometrium from ORIGENE TECHNOLOGIESCS5204055x5umORIGENE TECHNOLOGIES
Human Endometriotic tissue; Adenomyosis of myometrium from ORIGENE TECHNOLOGIESCS5226615x5umORIGENE TECHNOLOGIES
Human Endometriotic tissue; Adenomyosis of myometrium from ORIGENE TECHNOLOGIESCS5226625x5umORIGENE TECHNOLOGIES
Human Endometriotic tissue; Adenomyosis of myometrium from ORIGENE TECHNOLOGIESCS5280975x5umORIGENE TECHNOLOGIES
Human Endometriotic tissue; Adenomyosis of myometrium from ORIGENE TECHNOLOGIESCS6157415x5umORIGENE TECHNOLOGIES
Human Endometriotic tissue; Adenomyosis of myometrium from ORIGENE TECHNOLOGIESCS6207455x5umORIGENE TECHNOLOGIES
Human Endometriotic tissue; Adenomyosis of myometrium from ORIGENE TECHNOLOGIESCS6362645x5umORIGENE TECHNOLOGIES
Human Endometriotic tissue; Adenomyosis of myometrium from ORIGENE TECHNOLOGIESCS6407405x5umORIGENE TECHNOLOGIES
 |< < 3574 3575 3576 3577 3578 3579 3580 3581 3582 > >| 第 3577/6274 页